ID

20287

Description

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.; ODM derived from: https://clinicaltrials.gov/show/NCT00036218

Link

https://clinicaltrials.gov/show/NCT00036218

Keywords

Versions (1)
  1. 2/19/17 2/19/17 -
Uploaded on

February 19, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Parkinson Disease NCT00036218

English

Eligibility Parkinson Disease NCT00036218

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
parkinson's disease of less than 7 years duration
Description

parkinson

Data type

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0449238
modified hoehn and yahr scale stages 1 through 3.
Description

hoehn and yahr scale stage

Data type

boolean

Alias
UMLS CUI [1]
C4274318
age greater than or equal to 30 years old.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
men or women (women of childbearing potential must have a negative pregnancy test at screen) and both must use adequate contraceptive methods.
Description

contraceptive methods and gender

Data type

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C0079399
patients who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
Description

compliance

Data type

boolean

Alias
UMLS CUI [1]
C1321605
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
atypical parkinson's disease syndromes due to drugs, metabolic disorders, encephalitis, or degenerative diseases.
Description

atypical parkinsons disease

Data type

boolean

Alias
UMLS CUI [1]
C1868596
levodopa received for 1-year accumulated interval in the last two years.
Description

levodopa

Data type

boolean

Alias
UMLS CUI [1]
C0023570
dopamine agonist medications or catechol-o-methyl transferase inhibitors in the 30 days prior to baseline.
Description

dopamine agonist or catechol-o-methyl transferase inhibitors

Data type

boolean

Alias
UMLS CUI [1]
C0178601
UMLS CUI [2]
C2917201
unstable dose regimes of hypnotics, anxiolytics or antidepressants
Description

unstable dose regimes

Data type

boolean

Alias
UMLS CUI [1]
C4081662
dementia
Description

dementia

Data type

boolean

Alias
UMLS CUI [1]
C0497327
history of stereotaxic brain surgery, psychosis or active epilepsy within past year.
Description

stereotaxic brain surgery

Data type

boolean

Alias
UMLS CUI [1,1]
C0455610
UMLS CUI [1,2]
C0085203
UMLS CUI [2]
C0033975
UMLS CUI [3]
C0014544
participation in clinical trial within the previous 30 days.
Description

study subject participation status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
malignant melanoma or history of melanoma
Description

malignant melanoma or history of melanoma

Data type

boolean

Alias
UMLS CUI [1]
C0025202
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0025202
significant medical or psychiatric condition.
Description

illness

Data type

boolean

Alias
UMLS CUI [1]
C0221423
Back to the top of the page

Similar models

Eligibility Parkinson Disease NCT00036218

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
parkinson
Item
parkinson's disease of less than 7 years duration
boolean
C0030567 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
hoehn and yahr scale stage
Item
modified hoehn and yahr scale stages 1 through 3.
boolean
C4274318 (UMLS CUI [1])
age
Item
age greater than or equal to 30 years old.
boolean
C0001779 (UMLS CUI [1])
contraceptive methods and gender
Item
men or women (women of childbearing potential must have a negative pregnancy test at screen) and both must use adequate contraceptive methods.
boolean
C0700589 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
compliance
Item
patients who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
boolean
C1321605 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
atypical parkinsons disease
Item
atypical parkinson's disease syndromes due to drugs, metabolic disorders, encephalitis, or degenerative diseases.
boolean
C1868596 (UMLS CUI [1])
levodopa
Item
levodopa received for 1-year accumulated interval in the last two years.
boolean
C0023570 (UMLS CUI [1])
dopamine agonist or catechol-o-methyl transferase inhibitors
Item
dopamine agonist medications or catechol-o-methyl transferase inhibitors in the 30 days prior to baseline.
boolean
C0178601 (UMLS CUI [1])
C2917201 (UMLS CUI [2])
unstable dose regimes
Item
unstable dose regimes of hypnotics, anxiolytics or antidepressants
boolean
C4081662 (UMLS CUI [1])
dementia
Item
dementia
boolean
C0497327 (UMLS CUI [1])
stereotaxic brain surgery
Item
history of stereotaxic brain surgery, psychosis or active epilepsy within past year.
boolean
C0455610 (UMLS CUI [1,1])
C0085203 (UMLS CUI [1,2])
C0033975 (UMLS CUI [2])
C0014544 (UMLS CUI [3])
study subject participation status
Item
participation in clinical trial within the previous 30 days.
boolean
C2348568 (UMLS CUI [1])
malignant melanoma or history of melanoma
Item
malignant melanoma or history of melanoma
boolean
C0025202 (UMLS CUI [1])
C0262926 (UMLS CUI [2,1])
C0025202 (UMLS CUI [2,2])
illness
Item
significant medical or psychiatric condition.
boolean
C0221423 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial